Law360, New York (May 11, 2009, 12:00 AM ET) -- Reckitt Benckiser Inc. has filed another lawsuit against Watson Pharmaceuticals Inc. over the generic-drug maker's attempts to make its own version of the blockbuster cough treatment Mucinex.
The U.K.-based health care products company filed suit Friday in the U.S. District Court for the Southern District of New York accusing Watson and Watson Laboratories Inc.-Florida of infringing two patents for the drug.
The suit deals with Watson's attempts to make a generic version of Mucinex D, a version of the drug that contains both guaifenesin, the active...
Reckitt Benckiser Sues Watson Again Over Mucinex
To view the full article, take a free trial now.
